This was illustrated in an in vivo p53 wild-type breast cancer model where TIS was induced instead of cell death after chemotherapy treatment and resulted in minimal regression of the tumor and early relapse through the secretion of protumorigenic SASP [266]. Here, TP53 is linked to breast carcinoma.